BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1977716)

  • 21. Adrenal function in the Mongolian gerbil (Meriones unguiculatus): influence of confinement stress upon glucocorticosteroid, progesterone, dehydroepiandrosterone, testosterone and androstenedione plasma levels, adrenal content and in-vitro secretion.
    Fenske M
    Exp Clin Endocrinol; 1986 Jun; 87(1):15-25. PubMed ID: 3017731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome.
    Gambineri A; Forlani G; Munarini A; Tomassoni F; Cognigni GE; Ciampaglia W; Pagotto U; Walker BR; Pasquali R
    J Endocrinol Invest; 2009 Mar; 32(3):210-8. PubMed ID: 19542736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.
    Farah-Eways L; Reyna R; Knochenhauer ES; Bartolucci AA; Azziz R
    Fertil Steril; 2004 Jan; 81(1):120-5. PubMed ID: 14711554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal cortex and type II polycystic ovary syndrome.
    Devesa J; Perez-Fernandez R; Lima L; Cabezas-Cerrato J
    Gynecol Endocrinol; 1987 Sep; 1(3):269-77. PubMed ID: 2845714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
    Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
    Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
    Lobo RA; Goebelsmann U
    Am J Obstet Gynecol; 1980 Nov; 138(6):720-6. PubMed ID: 6254362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
    Samojlik E; Santen RJ
    J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome.
    Ditkoff EC; Fruzzetti F; Chang L; Stancyzk FZ; Lobo RA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):603-7. PubMed ID: 7852527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical growth hormone response following thyroid-stimulating hormone administration in the polycystic ovary syndrome.
    Anapliotou ML; Syrigos K; Panayiotakopoulos G; Kalos A; Batrinos ML
    Horm Res; 1989; 31(3):119-24. PubMed ID: 2501207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered adrenal steroid metabolism underlying hypercortisolism in female endurance athletes.
    Lindholm C; Hirschberg AL; Carlström K; von Schoultz B
    Fertil Steril; 1995 Jun; 63(6):1190-4. PubMed ID: 7750587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
    Yildiz BO; Woods KS; Stanczyk F; Bartolucci A; Azziz R
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5558-62. PubMed ID: 15531511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
    Luboshitzky R; Ishai A; Shen-Or Z; Herer P
    Neuro Endocrinol Lett; 2003; 24(3-4):249-54. PubMed ID: 14523365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
    Levine AC; Mitty HA; Gabrilove JL
    J Urol; 1988 Jul; 140(1):11-5. PubMed ID: 2967899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentrations of noncortisol adrenal steroids in response to ACTH in dogs with adrenal-dependent hyperadrenocorticism, pituitary-dependent hyperadrenocorticism, and nonadrenal illness.
    Monroe WE; Panciera DL; Zimmerman KL
    J Vet Intern Med; 2012; 26(4):945-52. PubMed ID: 22708651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients.
    Carmina E; Lobo RA
    Gynecol Endocrinol; 1990 Dec; 4(4):225-32. PubMed ID: 1964538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenocortical function in old age: response to acute adrenocorticotropin stimulation.
    Vermeulen A; Deslypere JP; Schelfhout W; Verdonck L; Rubens R
    J Clin Endocrinol Metab; 1982 Jan; 54(1):187-91. PubMed ID: 6274897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal function in subgroups of the PCO syndrome assessed by a long ACTH test.
    Kandeel FR; London DR; Butt WR; Davila N; Rudd BT; Sadeghian S; Lynch SS; Edwards RL; Horder M
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):601-12. PubMed ID: 6261995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of adrenal and ovarian catheterization in patients with polycystic ovary syndrome.
    Tzingounis VA; Aksu MF; Natrajan PK; Greenblatt RB
    Int J Gynaecol Obstet; 1978 Jul-1979 Aug; 17(1):78-82. PubMed ID: 39844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of estrogens on adrenal 3 beta-hydroxysteroid dehydrogenase in ovariectomized women.
    Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Sep; 43(3):561-70. PubMed ID: 182711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative sensitivity and responsivity of serum cortisol and two adrenal androgens to alpha-adrenocorticotropin-(1-24) in normal and obese, nonhirsute, eumenorrheic women.
    Komindr S; Kurtz BR; Stevens MD; Karas JG; Bittle JB; Givens JR
    J Clin Endocrinol Metab; 1986 Oct; 63(4):860-4. PubMed ID: 3018027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.